{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:10:22Z","timestamp":1786975822231,"version":"build-2736575974"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamapsychiatry.2019.0151","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T19:31:38Z","timestamp":1553715098000},"page":"691","source":"Crossref","is-referenced-by-count":25,"title":["Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia"],"prefix":"10.1001","volume":"76","author":[{"given":"Hannah E.","family":"Brown","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"},{"name":"Department of Psychiatry, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Freudenreich","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoduo","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, UMass Memorial Health Care and UMass Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen O.","family":"Heard","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, UMass Memorial Health Care and UMass Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Goff","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, NYU Langone Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Petrides","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Harrington","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, UMass Memorial Health Care and UMass Medical School, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Kane","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, New York"},{"name":"Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, New York"},{"name":"Department of Psychiatry, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"},{"name":"Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Judge","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hoeppner","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy H.","family":"Perlis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9831","key":"yoi190007r1","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"yoi190007r2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4088\/JCP.14074su1c.02","article-title":"Impact of cognitive and social cognitive impairment on functional outcomes in patients with schizophrenia.","volume":"77","author":"Green","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"yoi190007r3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4103\/2279-042X.128142","article-title":"Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis.","volume":"2","author":"Mousavi","year":"2013","journal-title":"J Res Pharm Pract"},{"issue":"11","key":"yoi190007r4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/0706743717718167","article-title":"Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis.","volume":"62","author":"Siskind","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"2","key":"yoi190007r5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.psc.2016.01.006","article-title":"Treatment-resistant schizophrenia.","volume":"39","author":"Elkis","year":"2016","journal-title":"Psychiatr Clin North Am"},{"issue":"7","key":"yoi190007r6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamapsychiatry.2013.1292","article-title":"Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial.","volume":"70","author":"Hallak","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"16","key":"yoi190007r7","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1523\/JNEUROSCI.5938-10.2011","article-title":"NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling.","volume":"31","author":"Szabadits","year":"2011","journal-title":"J Neurosci"},{"issue":"1","key":"yoi190007r8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/JCP.0000000000000258","article-title":"The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study.","volume":"35","author":"Maia-de-Oliveira","year":"2015","journal-title":"J Clin Psychopharmacol"},{"issue":"16","key":"yoi190007r9","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1017\/S0033291716002245","article-title":"The effect of sodium nitroprusside on psychotic symptoms and spatial working memory in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.","volume":"46","author":"Stone","year":"2016","journal-title":"Psychol Med"},{"issue":"3","key":"yoi190007r10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother Psychosom"},{"issue":"2","key":"yoi190007r11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"2","key":"yoi190007r12","first-page":"343","article-title":"SAFTEE: a technique for the systematic assessment of side effects in clinical trials.","volume":"22","author":"Levine","year":"1986","journal-title":"Psychopharmacol Bull"},{"issue":"11","key":"yoi190007r13","first-page":"1172","article-title":"How to examine patients using the Abnormal Involuntary Movement Scale.","volume":"39","author":"Munetz","year":"1988","journal-title":"Hosp Community Psychiatry"},{"issue":"12","key":"yoi190007r14","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"6","key":"yoi190007r16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/schbul\/sbm014","article-title":"Development of a brief scale of everyday functioning in persons with serious mental illness.","volume":"33","author":"Mausbach","year":"2007","journal-title":"Schizophr Bull"},{"issue":"4","key":"yoi190007r17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1740774507081217","article-title":"An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.","volume":"4","author":"Tamura","year":"2007","journal-title":"Clin Trials"},{"issue":"23","key":"yoi190007r18","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/sim.4292","article-title":"Optimality, sample size, and power calculations for the sequential parallel comparison design.","volume":"30","author":"Ivanova","year":"2011","journal-title":"Stat Med"},{"issue":"2-3","key":"yoi190007r19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr Res"},{"key":"yoi190007r20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.psychres.2018.08.079","article-title":"Sodium nitroprusside treatment for psychotic symptoms and cognitive deficits of schizophrenia: a randomized, double-blind, placebo-controlled trial.","volume":"269","author":"Wang","year":"2018","journal-title":"Psychiatry Res"},{"issue":"5","key":"yoi190007r21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1017\/S003329171600307X","article-title":"Letter to the Editor: Sodium nitroprusside for schizophrenia: could methodological variables account for the different results obtained?","volume":"47","author":"Maia-de-Oliveira","year":"2017","journal-title":"Psychol Med"},{"issue":"10","key":"yoi190007r22","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2165\/11586650-000000000-00000","article-title":"Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.","volume":"25","author":"Singh","year":"2011","journal-title":"CNS Drugs"},{"issue":"6","key":"yoi190007r23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/JCP.0000000000000217","article-title":"Sodium nitroprusside treatment of clozapine-refractory schizophrenia.","volume":"34","author":"Maia-de-Oliveira","year":"2014","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"yoi190007r24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pscychresns.2011.06.013","article-title":"Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI.","volume":"194","author":"Pinkham","year":"2011","journal-title":"Psychiatry Res"},{"issue":"4","key":"yoi190007r25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: a clinical concepts review.","volume":"30","author":"Hottinger","year":"2014","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"4-6","key":"yoi190007r26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis.","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell Mol Neurobiol"},{"issue":"7346","key":"yoi190007r27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09915","article-title":"Modelling schizophrenia using human induced pluripotent stem cells.","volume":"473","author":"Brennand","year":"2011","journal-title":"Nature"},{"issue":"6","key":"yoi190007r28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.neuint.2004.03.021","article-title":"Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation.","volume":"45","author":"Contestabile","year":"2004","journal-title":"Neurochem Int"},{"issue":"3-4","key":"yoi190007r29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity.","volume":"10","author":"Dawson","year":"1996","journal-title":"J Chem Neuroanat"},{"issue":"4","key":"yoi190007r30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrcardio.2013.8","article-title":"The biology behind the atherothrombotic effects of cigarette smoke.","volume":"10","author":"Csordas","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"yoi190007r15","volume-title":"MATRICS Consensus Cognitive Battery Manual","author":"Nuechterlein","year":"2006"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamapsychiatry\/article-pdf\/76\/7\/691\/17674235\/jamapsychiatry_brown_2019_oi_190007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:01:08Z","timestamp":1562151668000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2019.0151"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0151","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}